Long Term Intravenous Inotropes in Advanced Heart Failure Are Associated With Decrease in Hospitalized Days and Improved Functional Class

Journal of Cardiac Failure - United States
doi 10.1016/j.cardfail.2019.07.186
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Quality of Life and Long-Term Mortality in Patients With Advanced Chronic Heart Failure Treated With Intermittent Low-Dose Intravenous Inotropes in an Outpatient Setting

ESC heart failure
Cardiovascular MedicineCardiology
2016English

Inotropes in Acute Heart Failure

Continuing Cardiology Education
2017English

Long-Term Mortality Risk in Hospitalized Patients With Heart Failure After Myocardial Infarction

Russian Journal of Cardiology
Cardiovascular MedicineCardiology
2020English

Interim Analysis of the INTERPRET Patient Registry Program of Advanced Heart Failure Patients Treated With Intravenous Inotropes in the Ambulatory Setting

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2016English

Beta-Blocker Use at Discharge in Patients Hospitalized for Heart Failure Is Associated With Improved Survival

Circulation Journal
MedicineCardiovascular MedicineCardiology
2010English

Predictors of Long-Term Adverse Outcomes in Elderly Patients Over 80 Years Hospitalized With Heart Failure

Circulation Journal
MedicineCardiovascular MedicineCardiology
2011English

Long-Term Studies With Xamoterol in Heart Failure.

British Journal of Clinical Pharmacology
Pharmacology
1989English

Long-Term Dobutamine in Heart Failure.

Postgraduate Medical Journal
Medicine
1994English

HE4 Serum Levels Are Associated With Heart Failure Severity in Patients With Chronic Heart Failure

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy